Consistent with the action of AZ505, conditional knockdown of Smyd2 also significantly ameliorated cisplatin‐induced chronic kidney injury, indicating a critical role for SMYD2 in cisplatin‐induced nephrotoxic CKD. The gene discussed is SMYD2; the disease is chronic kidney disease.